Markus Laimer

[Michael Riddell, PhD @MCRiddell1]

This will make a significant contribution to the #T1D and #exercise clinical space. Well done @othmar_moser and team!

[Danish Diabetes and Endocrine Academy @DDEA_Denmark]

Are you curious to hear how the DDA & DDSA event, Data Science Spring School went? We talked with the organisers, @adamhulman & @metabolady, and two participants to hear more about the aim of the event and the experience: 👉🏻https://t.co/p9FlxJFsff

[Team Novo Nordisk @teamnovonordisk]

The survey created by the University of Bern, Switzerland to gather information on challenges and risks to people living with type 1 diabetes during the #COVID2019 pandemic is now available in German, Italian & Spanish.

https://t.co/JZFeQyDoox

#ChangingDiabetes

[Universität Bern @unibern]

Forschende des @DBMR_UniBE und @inselgruppe führen eine weltweit einzigartige Umfrage durch zu #diabetestyp1 und #COVID19. Betroffene können sich melden, die Einträge lassen sich interaktiv in Echtzeit verfolgen. https://t.co/0gpeSi8Awc
@dc_berne

[Sam Scott, PhD @SamNathanScott]

Do you have #type1diabetes? Please complete our questionnaire to help us understand your experiences during the #COVID19 pandemic

Here’s the survey: https://t.co/jq9gPeWaGu

Please RT

More info: https://t.co/LvDq9jTGfH

[Markus Laimer @markuslaimer]

https://t.co/Bk3G9CWtmU

[Dana M. Lewis | #OpenAPS 🤖 @danamlewis]

Blown away by the number of close loopers in the room. Thanks everyone for sharing! 💜 #docday #EASD2019

[Lukas Froesch @_lzf]

Join our team and our mission! #EASD2019 #EASD #diabetes #research

[Dana M. Lewis | #OpenAPS 🤖 @danamlewis]

And also oral presentation Glycemic Control in People with Type 1 Diabetes Using Open Source Artificial Pancreas Systems from @AndreasMelmer with @ChriStettler, @thomaszueger, @markuslaimer, @scottleibrand @danamlewis: https://t.co/scFiQhX0O9 #ADA2019

[Markus Laimer @markuslaimer]

@diaTribeNews @OpenAPS Andreas Melmer did a great presentation - and we are happy that he is now part of our team in Bern.

[Dana M. Lewis | #OpenAPS 🤖 @danamlewis]

Also, incidence of hypoglycemic events was reduced after initiating DIYAPS. #ADA2019

[Dana M. Lewis | #OpenAPS 🤖 @danamlewis]

There are now multiple different kinds of DIYAPS systems in use: #OpenAPS, Loop, and AndroidAPS. There are differences in hardware, pump, and software configurations. The algorithm for OpenAPS is also used in AndroidAPS. #ADA2019

[Dana M. Lewis | #OpenAPS 🤖 @danamlewis]

Thread from “Glycemic Control and Glycemic Variability in People with Type 1 Diabetes Using Open Source Artificial Pancreas Systems”, presented by Andreas Melmer, incl. @dcberne1 colleagues @ChriStettler, @thomaszueger, @markuslaimer, & @scottleibrand & @DanaMLewis. #ADA2019

[Christoph Stettler @ChriStettler]

UDEM presence at ADA 2019 Scientific Session - double hit!

[Tim Street @Tims_Pants]

⁦@howardlook⁩ announces ⁦@Dexcom⁩ as the iCGM partner for ⁦@Tidepool_org⁩ loop at #ddata19

[Tidepool @Tidepool_org]

You probably didn’t see this coming, we’ve announced an agreement to partner with our friends at @MDT_Diabetes to support a future Bluetooth-enabled MiniMed™ pump with Tidepool Loop. Read more here: https://t.co/AOT0HAZ3x1

[Markus Laimer @markuslaimer]

Tomorrow Andreas Melmer presents analysis of OpenAPS data. I am looking forward to an exciting session. #ADA2019 @danamlewis @scottleibrand @dcberne1 @thomaszueger

[Breakthrough T1D Canada @BT1D_CA]

.@max_domi surprised hockey players at D-Skate and spoke to the kids about overcoming daily challenges with the help of the CONTOUR® NEXT ONE Smart Meter and CONTOUR® DIABETES App.

Retweet and @contourascensia will donate $1 to JDRF. #NDAM2018 #contournextone #contourascensia